HCP, Inc. (HCP): The Spin Benefit Is In The Price - UBS

August 23, 2016 8:47 AM EDT
Get Alerts HCP Hot Sheet
Price: $30.53 +1.03%

Rating Summary:
    3 Buy, 16 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 35 | Down: 31 | New: 9
Trade HCP Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

UBS analyst, Nick Yulico, reiterated his Neutral rating on shares of HCP (NYSE: HCP) since the current valuation factors in the bulk of the benefit from HCP's plan to spin off its skilled nursing assets.

The analyst went on to state that key takeaways from 2Q results include:

1) Cash SSNOI guidance for FY16 was unchanged at 1.5%-2.5%.

2) The focus remains on HCR ManorCare until that portfolio is spun out as its own entity (Quality Care Partners, or QCP)

3) HCRMC's 2Q EBITDAR was flat q/q, but TTM fixed charge coverage was barely

above 1.0x (1.03x vs. 1.06x in 1Q).

4) EBITDAR at HCRMC remains under pressure due to tough operator occupancy and a shift to managed care.

The price price target increases to $38.00 from $35.00.

For an analyst ratings summary and ratings history on HCP click here. For more ratings news on HCP click here.

Shares of HCP closed at $39.42 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS View

Related Entities


Add Your Comment